Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
Clinical trial NCT00203424 · COMPLETED
Trial details
- NCT number
- NCT00203424
- Sponsor
- Translational Oncology Research International
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2009-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.